BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38181288)

  • 1. Relationship between trimethylamine N-oxide and the risk of hypertension in patients with cardiovascular disease: A meta-analysis and dose-response relationship analysis.
    Han JM; Guo L; Chen XH; Xie Q; Song XY; Ma YL
    Medicine (Baltimore); 2024 Jan; 103(1):e36784. PubMed ID: 38181288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut Microbial Metabolite Trimethylamine N-Oxide and Hypertension Risk: A Systematic Review and Dose-Response Meta-analysis.
    Ge X; Zheng L; Zhuang R; Yu P; Xu Z; Liu G; Xi X; Zhou X; Fan H
    Adv Nutr; 2020 Jan; 11(1):66-76. PubMed ID: 31269204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-associated trimethylamine N-oxide and increased cardiometabolic risk in adults: a systematic review and dose-response meta-analysis.
    Abbasalizad Farhangi M; Vajdi M
    Nutr Rev; 2021 Aug; 79(9):1022-1042. PubMed ID: 33270896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
    Yang WT; Yang R; Zhao Q; Li XD; Wang YT
    Ann Palliat Med; 2021 Nov; 10(11):11512-11523. PubMed ID: 34872276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis.
    Dehghan P; Farhangi MA; Nikniaz L; Nikniaz Z; Asghari-Jafarabadi M
    Obes Rev; 2020 May; 21(5):e12993. PubMed ID: 32017391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis.
    Guasti L; Galliazzo S; Molaro M; Visconti E; Pennella B; Gaudio GV; Lupi A; Grandi AM; Squizzato A
    Intern Emerg Med; 2021 Jan; 16(1):201-207. PubMed ID: 32779113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: A systematic review and dose-response meta-analysis.
    Zhuang R; Ge X; Han L; Yu P; Gong X; Meng Q; Zhang Y; Fan H; Zheng L; Liu Z; Zhou X
    Obes Rev; 2019 Jun; 20(6):883-894. PubMed ID: 30868721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.
    Qi J; You T; Li J; Pan T; Xiang L; Han Y; Zhu L
    J Cell Mol Med; 2018 Jan; 22(1):185-194. PubMed ID: 28782886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.
    Li D; Lu Y; Yuan S; Cai X; He Y; Chen J; Wu Q; He D; Fang A; Bo Y; Song P; Bogaert D; Tsilidis K; Larsson SC; Yu H; Zhu H; Theodoratou E; Zhu Y; Li X
    Am J Clin Nutr; 2022 Jul; 116(1):230-243. PubMed ID: 35348578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis.
    Farhangi MA; Vajdi M; Asghari-Jafarabadi M
    Nutr J; 2020 Jul; 19(1):76. PubMed ID: 32731904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
    Zhang H; Yao G
    Eur J Clin Nutr; 2023 Jul; 77(7):731-740. PubMed ID: 35468932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
    Thomas MS; Fernandez ML
    Curr Atheroscler Rep; 2021 Feb; 23(4):12. PubMed ID: 33594574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Tatsanavivat P; Sritara P; Phrommintikul A
    Sci Rep; 2021 Jul; 11(1):14963. PubMed ID: 34294762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum gut microbe-dependent trimethylamine N-oxide improves the prediction of future cardiovascular disease in a community-based general population.
    Zheng L; Zheng J; Xie Y; Li Z; Guo X; Sun G; Sun Z; Xing F; Sun Y
    Atherosclerosis; 2019 Jan; 280():126-131. PubMed ID: 30508691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel findings of the association between gut microbiota-derived metabolite trimethylamine
    Farhangi MA; Vajdi M
    Crit Rev Food Sci Nutr; 2020; 60(16):2801-2823. PubMed ID: 32462890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular disease.
    Bean LD; Wing JJ; Harris RE; Smart SM; Raman SV; Milks MW
    BMC Cardiovasc Disord; 2022 May; 22(1):209. PubMed ID: 35538408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmatic trimethylamine N-oxide and its relation to stroke: A systematic review and dose-response meta-analysis.
    Chen P; Guo Z
    Medicine (Baltimore); 2022 Jul; 101(29):e29512. PubMed ID: 35866835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.